Teva jumps on Berkshire Hathaway investment

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA) gained $1.77 to $21.10 in after-hours trading on Wednesday after Berkshire Hathaway Inc. (NYSE:BRK-A; NYSE:BRK-B) disclosed a new stake in the generics company.

In an SEC filing issued after market close, Berkshire reported owning 18.9 million American Depositary Receipts (ADRs) of Teva as of Dec. 31, 2017. The stake is valued at $365 million based on Teva's Wednesday close of $19.33...